The first 2 and the last author (ie. the most significant ones) have all received payment from the company making PCT testing. Does that just mean they are interested in the topic? Is it unreasonable to ask for no conflict of interest?
Our patients are part of this population but not huge in number. Does that make the results irrelevant to us, or is there a lot we can still learn?
What do the results tell us about how we should use PCT? Do we do that currently?
What do you think of the blinding strategy - adequate?
The study had antibiotic use as it's focus, not patient outcome. The benefits are therefore to the population rather than the individual patient. Do you agree?
The protocol was overruled in 1/5 of patients. Is this a reflection on the
study design the test, or the physicians involved?